Content area

Abstract

Background

Viral pneumonia is the most common and lethal pandemic disease, but there are no broad-spectrum antiviral drugs with high genetic barriers to resistance. To elucidate the mechanisms of viral pneumonia progression and potential targets for its treatment.

Methods

Viral pneumonia models were induced by the PR8 virus strain in wild-type (WT) and STING knockout (STING-KO) mice. Series of molecular biology techniques were used to evaluate the severity of pneumonia and cytokine levels.

Results

In this study, STING (stimulator of interferon genes) was activated in the lungs of virus-infected mice, leading to cytokine production and amplification of the immune response, thereby causing rapid deterioration of symptoms. Furthermore, excessive activation of innate immune response via STING was prevented by a STING inhibitor (C-176), which significantly reduced viral lung inflammation. The formation of neutrophil extracellular traps (NETs) was similarly suppressed during viral pneumonia treatment with STING inhibitors (C-176), and NETs formation and STING expression were positively correlated, indicating that STING plays an important role in NETs formation. Symptoms of pneumonia in STING-KO mice infected with PR8 were significantly milder than those in WT mice, and NETs were less likely to form in the lung tissue of STING-KO mice. Additionally, transcriptomic analysis revealed that STING-mediated regulation of NETs may be associated with gasdermin D (GSDMD), and immunoprecipitation experiments revealed that STING, GSDMD, and NETs-related proteins interact with each other. Immunofluorescence assays revealed that in neutrophils from WT mice, STING and GSDMD were colocalized on the membrane after viral infection, whereas in neutrophils from STING-KO mice, GSDMD expression was decreased after exposure to the virus.

Conclusions

Our study demonstrated that targeted intervention with STING alleviated pneumonia by inhibiting inflammation and NETs formation. The study also revealed that blocking STING could inhibit the activation of GSDMD to inhibit NETs formation, slowing the progression of viral pneumonia.

Details

1009240
Title
STING regulates NETs formation by activating GSDMD in influenza viral pneumonia
Author
Huang, Rongrong 1 ; Chen, Ranran 1 ; Xing, Lijuan 1 ; Wu, Lianhao 1 ; Zhu, Wenwen 2 ; Jing, Junsong 1 ; Zhou, Ting 2 ; Wu, Yueguo 2 ; Zhang, Sheng 3 ; You, Zhenqiang 1 

 School of Basic Medical Sciences & Forensic Medicine, Hangzhou Medical College, Hangzhou, China, School of Public Health, Hangzhou Medical College, Hangzhou, China, Key Discipline of Zhejiang Province in Public Health and Preventive Medicine (First Class, Category A), Hangzhou Medical College, Hangzhou, China 
 School of Basic Medical Sciences & Forensic Medicine, Hangzhou Medical College, Hangzhou, China 
 Center for Safety Evaluation and Research, Hangzhou Medical College, Hangzhou, China 
Publication title
Volume
16
First page
1598902
Number of pages
20
Publication year
2025
Publication date
Jul 2025
Section
Viral Immunology
Publisher
Frontiers Media SA
Place of publication
Lausanne
Country of publication
Switzerland
Publication subject
e-ISSN
16643224
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
 
 
Online publication date
2025-07-01
Milestone dates
2025-03-24 (Recieved); 2025-06-09 (Accepted)
Publication history
 
 
   First posting date
01 Jul 2025
ProQuest document ID
3278302310
Document URL
https://www.proquest.com/scholarly-journals/sting-regulates-nets-formation-activating-gsdmd/docview/3278302310/se-2?accountid=208611
Copyright
© 2025. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2025-12-19
Database
2 databases
  • Coronavirus Research Database
  • ProQuest One Academic